Evidence map›Paper›PMID 41278050›Full record

ArticleCureus2025

Novel Use of RegJointTM in the Management Talocalcaneal Coalition Interpositional Arthroplasty.

Canan Metin, Shah Khan, Henry Atkinson

Abstract readCase Reports
In one paragraph

Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Canan MetinTrauma and Orthopaedic Surgery, North Middlesex University Hospital, London, GBR.
Shah KhanTrauma and Orthopaedics, North Middlesex University Hospital, London, GBR.
Henry AtkinsonTrauma and Orthopaedic Surgery, North Middlesex University Hospital, London, GBR.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

RegJoint™ is a bioresorbable porous polylactide scaffold that has previously been used as an interposition device in small joint arthritis of the hand and great toe. The preformed design of RegJoint™ offers the technical advantages over autologous grafts by maintaining a consistent joint space volume during healing. This case represents the first documented use of a RegJoint™ implant as an interposition arthroplasty in the treatment of symptomatic talocalcaneal coalition. There were no complications, and the patient was able to return to pain-free light exercise after three months, with a return to full contact sports after six months. The device offers potential advantages, such as precise sizing and a reduction in donor-site morbidity. The mid-term outcome in our patient suggests that this technique might provide, at the very least, comparable pain relief and functional recovery to established methods.

Indexed as

adolescent athletefoot and ankle surgeryinterposition arthroplastyregjoint implantsynthetic implanttalocalcaneal coalitiontarsal coalition

Identifiers

PMID41278050
PMCPMC12635896

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.